Establishing rarity in the context of orphan medicinal product designation in the European Union

Author:

Tsigkos Stelios,Hofer Matthias Philipp,Sheean Maria Elzbieta,Mariz Segundo,Larsson Kristina,Naumann-Winter Frauke,Fregonese Laura,Sepodes Bruno

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference25 articles.

1. European Parliament and Council, Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999, Official Journal of the European Communities, L 18, 22 January 2000, 1-5.

2. EC, Commission Regulation (EC) No 847/2000 of 27 April 2000 Laying Down the Provisions for Implementation of the Criteria for Designation of a Medicinal Product and Definitions of the Concepts ‘Similar Medicinal Product’ and ‘Clinical Superiority’, Official Journal of the European Communities, L 103, 28 April 2000, 5-8.

3. Points to Consider on the Calculation and Reporting of the Prevalence of a Condition for Orphan Designation, 26 March 2002 COMP/436/01;COMP,2002

4. Guideline on the Format and Content of Applications for Designation as Orphan Medicinal Products and on the Transfer of Designations from One Sponsor to Another (ENTR/6283/00);EC,2007

5. Relevant Sources for Orphan Disease Prevalence Data;EMA,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3